The Retinopathy Drug market is a subset of the Optical Disorders Drugs market, which includes drugs used to treat diseases of the eye. Retinopathy drugs are used to treat diseases of the retina, such as age-related macular degeneration, diabetic retinopathy, and retinitis pigmentosa. These drugs can be administered orally, topically, or by injection. Commonly used retinopathy drugs include anti-VEGF agents, corticosteroids, and photodynamic therapy. The Retinopathy Drug market is highly competitive, with many companies developing and marketing drugs to treat retinopathy. Some of the major players in the market include Regeneron Pharmaceuticals, Novartis, Allergan, Roche, and Bayer. Show Less Read more
ASK A QUESTION
We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.
